Home  |   Archive  |   Online Submission  |   News & Events  |   Subscribe  |   APFA  |   Society  |   Contact Us  |   中文版
Search   
 
Journal

-Ahead of print
-Authors' Accepted
    Manuscripts
new!
-Current Issue
-Archive
-Acknowledgments
-Special Issues
-Browse by Category

Manuscript Submission

-Online Submission
-Online Review
-Instruction for Authors
-Instruction for Reviewers
-English Corner new!

About AJA

-About AJA
-Editorial Board
-Contact Us
-News

Resources & Services

-Advertisement
-Subscription
-Email alert
-Proceedings
-Reprints

Download area

-Copyright licence
-EndNote style file
-Manuscript word template
-Guidance for AJA figures
    preparation (in English)

-Guidance for AJA figures
    preparation (in Chinese)

-Proof-reading for the
    authors

-AJA Club (in English)
-AJA Club (in Chinese)

 
中文摘要

《亚洲男性学杂志》 2012; 14 (3): 493-498

《亚洲男性学杂志》 2012; 14 (3): 493–498

NKX3.1对前列腺癌PC3细胞中IGF-1R的表达及其信号转导通路的抑制作用研究

Peng-Ju Zhang, Xiao-Yan Hu, Chun-Yan Liu, Zhao-Bo Chen, Na-Na Ni, Yang Yu, Li-Na Yang, Zhao-Qin Huang, Qing-Wei Liu, An-Li Jiang (中国)

人同源盒基因NKX3.1在前列腺中特异表达与前列腺癌的发生、发展密切相关,该基因通常作为抑癌基因发挥作用。本实验旨在研究NKX3.1对前列腺癌细胞PC3中IGF-1R的表达及其信号通路的影响。NKX3.1真核表达载体pcDNA3.1-NKX3.1稳定转染PC3细胞,稳定转染空载体组作为对照。RT-PCR和Western blotting 分别检测两组细胞中IGF-1R mRNA 和蛋白质的表达;Western blotting和荧光素酶报告基因检测IGF-1/IGF-1R信号通路下游分子的表达和活性;不同浓度IGF-1处理上述两组细胞,MTT和流式细胞术检测细胞生长增殖。结果显示,NKX3.1在PC3细胞中表达后大大降低了IGF-1R mRNA和蛋白质的表达,同时抑制了IGF-1诱导的ERK1/2和AKT的磷酸化、Elk-1转录因子活性及下游靶基因c-fos和cyclinD1的表达;另外,NKX3.1表达后,显著抑制了IGF-1对细胞增殖的诱导作用。我们从中得出结论:NKX3.1能够降低PC3细胞中IGF-1R的表达,抑制IGF-1R介导的MAPK/ERK和AKT信号通路,从而抑制IGF-1诱导的细胞增殖。本研究阐明了NKX3.1抑制肿瘤的新的分子机制,并为前列腺癌的治疗提供了新的思路。

关键词:IGF-1, IGF-1R, NKX3.1, 前列腺癌

此摘要文献来源:
Peng-Ju Zhang, Xiao-Yan Hu, Chun-Yan Liu, Zhao-Bo Chen, Na-Na Ni, Yang Yu, Li-Na Yang, Zhao-Qin Huang, Qing-Wei Liu, An-Li Jiang. The inhibitory effects of NKX3.1 on IGF-1R expression and its signalling pathway in human prostatic carcinoma PC3 cells. Asian J Androl 2012; 14: 493–498.

 
Asian Journal of Andrology CN 31-1795/R ISSN 1008-682X  Copyright © 2023  Shanghai Materia Medica, Chinese Academy of Sciences.  All rights reserved.